Comments Regarding FDA Diversity Action Plans to Improve Enrollment of Participants From Underrepresented Populations in Clinical Studies Share page: Docket Number: FDA–2021–D–0789 Download Document Issues: OTC Medicines Dietary Supplements Consumer Medical Devices Other Issues Research Related Posts Comments Comments Regarding Enhancing Coverage of Preventative Services Under the Affordable Care Act Dec 26, 2024 Comments Comments Regarding Control of Nitrosamine Impurities in Human Drugs Dec 20, 2024 Press Releases and Statements Rates for Teen Abuse of OTC Cough/Cold Medication Remains Low According to NIDA Survey Dec 18, 2024
